Johnson & Johnson Signs Software Agreement with Desert Scientific Software

Johnson & Johnson, one of the world’s largest healthcare providers, has licensed Proasis2®, Desert Scientific Software’s protein structure database and visualization system.

Desert Scientific Software (DesertSci), a chemo/bioinformatics software company based in Sydney, Australia is pleased to announce the licensing of their flagship product, Proasis2®, by Johnson and Johnson Pharmaceutical R&D, L.L.C, in San Diego, CA.
Proasis2® continues to be the industry’s leading protein structure database and visualisation system for medicines research. In one complete system it combines a superior relational database for storing, retrieving, and searching structures important to medicinal chemistry projects with an intuitive desktop visualization system for exploring those structures. Developed in collaboration with most of the top ten global pharmaceutical companies, Proasis2® matches the real requirements of leading edge drug discovery. It is an invaluable tool for scientists working in structural biology and for scientists working with structural biology data.

Click here to learn more about Proasis2